GSBGEN 551:
Innovation and Management in Health Care
The health care system accounts for over 17% of US GDP and is one of the fastest growing segments of the economy. This two unit class focuses on the interplay and tension between the main players in the health care field - providers of health care services (individual doctors, group practices, integrated health care systems), payors (insurances companies, employers, consumers, and government), patients, and innovator companies (biopharma, medical device, diagnostics, and health care IT). The course is designed for students with a broad diversity of backgrounds and interests who want to better understand the health care business and system. No prior experience in the health care or medical field is assumed or needed. The focus of the class will be primarily on the US health care system, but there will be limited discussion of non-US systems as well. nnnThe course is divided into five modules: nn1. An overview of the US Health Care System and the interplay between payers, providers, and innovatorsnn2. Provider organization models and incentive structuresnn - The relationship between quality, cost, and accessnn - Integrated systems and fee for service modelsnn - New IT technologies, including electronic data records, and incentives for adoption nn - How the delivery system structure affects technology innovatorsnn3. Innovator business models and issuesnn - Financing and managing new product development and portfolio managementnn - Clinical trial management and gaining regulatory approvalnn - Marketing, communication and sales strategies (both physician and patient communication and sales) to drive product adoption and gain third party reimbursementnn - Business models to drive innovationnn4. New technologies, business opportunities, and business modelsnn - Molecular diagnosticsnn - Stem cells and regenerative medicinenn - Consumer genomicsnn5. Health care system reform nnnThe class will be taught primarily from the perspective of a business person operating a company rather than that of a policy maker, academic, or investor. While there will be a few lectures to provide background and frameworks for course topics, most classes will involve a case discussion and prominent guest speakers from the health care industry. Speakers and panelists in previous years included CEOs and senior executives from Genentech, Gilead, Onyx Pharmaceuticals, Medtronic, Jazz Pharmaceuticals, and Genomic Health; venture investors from Essex Woodland Health Ventures and Prospect Ventures; and heads of the health care/biotech practices at McKinsey and Goldman Sachs.
Terms: Win
| Units: 2